A detailed history of Garrison Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Garrison Asset Management, LLC holds 2,577 shares of LLY stock, worth $2.28 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares
2,577
Previous 2,697 4.45%
Holding current value
$2.28 Million
Previous $2.1 Million 11.2%
% of portfolio
1.27%
Previous 1.12%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$724.87 - $909.04 $86,984 - $109,084
-120 Reduced 4.45%
2,577 $2.33 Million
Q4 2023

May 24, 2024

SELL
$525.19 - $619.13 $48,317 - $56,959
-92 Reduced 3.3%
2,697 $1.57 Million
Q4 2023

Feb 01, 2024

SELL
$525.19 - $619.13 $48,317 - $56,959
-92 Reduced 3.3%
2,697 $1.57 Million
Q3 2023

May 24, 2024

BUY
$434.7 - $599.3 $28,690 - $39,553
66 Added 2.42%
2,789 $1.5 Million
Q3 2023

Oct 23, 2023

BUY
$434.7 - $599.3 $28,690 - $39,553
66 Added 2.42%
2,789 $1.5 Million
Q2 2023

May 24, 2024

SELL
$350.74 - $468.98 $37,178 - $49,711
-106 Reduced 3.75%
2,723 $1.28 Million
Q2 2023

Aug 03, 2023

SELL
$350.74 - $468.98 $37,178 - $49,711
-106 Reduced 3.75%
2,723 $1.23 Million
Q1 2023

May 24, 2024

SELL
$310.63 - $364.82 $27,956 - $32,833
-90 Reduced 3.08%
2,829 $971,000
Q1 2023

Apr 28, 2023

SELL
$310.63 - $364.82 $27,956 - $32,833
-90 Reduced 3.08%
2,829 $972,000
Q4 2022

May 24, 2024

BUY
$321.55 - $374.67 $71,384 - $83,176
222 Added 8.23%
2,919 $1.07 Million
Q4 2022

Feb 07, 2023

SELL
$321.55 - $374.67 $5,787 - $6,744
-18 Reduced 0.61%
2,919 $1.07 Million
Q3 2022

Oct 21, 2022

SELL
$296.48 - $337.87 $17,788 - $20,272
-60 Reduced 2.0%
2,937 $950,000
Q2 2022

Aug 08, 2022

SELL
$278.73 - $327.27 $44,596 - $52,363
-160 Reduced 5.07%
2,997 $972,000
Q1 2022

May 09, 2022

SELL
$234.69 - $291.66 $5,397 - $6,708
-23 Reduced 0.72%
3,157 $904,000
Q4 2021

Jan 25, 2022

SELL
$224.85 - $279.04 $15,064 - $18,695
-67 Reduced 2.06%
3,180 $878,000
Q3 2021

Oct 20, 2021

SELL
$221.6 - $272.71 $4,653 - $5,726
-21 Reduced 0.64%
3,247 $750,000
Q2 2021

Jul 21, 2021

SELL
$180.55 - $233.54 $8,305 - $10,742
-46 Reduced 1.39%
3,268 $750,000
Q1 2021

Apr 21, 2021

BUY
$164.32 - $212.72 $2,629 - $3,403
16 Added 0.49%
3,314 $619,000
Q4 2020

Feb 02, 2021

SELL
$130.46 - $172.63 $371,550 - $491,650
-2,848 Reduced 46.34%
3,298 $557,000
Q3 2020

Oct 28, 2020

SELL
$146.22 - $169.13 $10,966 - $12,684
-75 Reduced 1.21%
6,146 $910,000
Q2 2020

Aug 06, 2020

SELL
$136.42 - $164.18 $27,283 - $32,836
-200 Reduced 3.11%
6,221 $1.02 Million
Q1 2020

May 04, 2020

SELL
$119.05 - $147.35 $13,928 - $17,239
-117 Reduced 1.79%
6,421 $891,000
Q4 2019

Feb 10, 2020

SELL
$106.92 - $132.43 $4,276 - $5,297
-40 Reduced 0.61%
6,538 $859,000
Q3 2019

Nov 08, 2019

SELL
$106.79 - $116.16 $7,261 - $7,898
-68 Reduced 1.02%
6,578 $736,000
Q2 2019

Jul 25, 2019

SELL
$110.79 - $129.32 $7,090 - $8,276
-64 Reduced 0.95%
6,646 $736,000
Q1 2019

May 06, 2019

SELL
$111.31 - $131.02 $8,236 - $9,695
-74 Reduced 1.09%
6,710 $871,000
Q4 2018

Feb 06, 2019

SELL
$105.9 - $118.64 $171,134 - $191,722
-1,616 Reduced 19.24%
6,784 $785,000
Q4 2018

Feb 05, 2019

BUY
$105.9 - $118.64 $94,992 - $106,420
897 Added 11.96%
8,400 $674,000
Q3 2018

Nov 02, 2018

SELL
$85.86 - $107.31 $54,864 - $68,571
-639 Reduced 7.85%
7,503 $805,000
Q2 2018

Aug 10, 2018

BUY
$75.7 - $86.88 $9,159 - $10,512
121 Added 1.51%
8,142 $695,000
Q1 2018

May 07, 2018

BUY
$74.21 - $87.6 $30,500 - $36,003
411 Added 5.4%
8,021 $621,000
Q3 2017

Oct 30, 2017

BUY
$77.07 - $85.54 $586,502 - $650,959
7,610
7,610 $651,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $842B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Garrison Asset Management, LLC Portfolio

Follow Garrison Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garrison Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Garrison Asset Management, LLC with notifications on news.